Lemieux Stephen 4/A
4/A · Edesa Biotech, Inc. · Filed Jul 24, 2023
Insider Transaction Report
Form 4/AAmended
Lemieux Stephen
Chief Financial Officer
Transactions
- Award
Share Option (right to buy)
2023-07-20+75,000→ 75,000 totalExercise: $0.83Exp: 2033-07-20→ Common Shares (75,000 underlying)
Footnotes (1)
- [F1]This option vests monthly in equal proportions over 36 months beginning on the date of grant.